KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: Implications for therapy

Trends in Neurosciences

Volumn 23, Issue 9, 2000, Pages 393-398

  Rogawski, Michael A ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; MEXILETINE; POTASSIUM CHANNEL;

ANIMAL CELL; CONTROLLED STUDY; DRUG TARGETING; FAMILIAL DISEASE; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC SUSCEPTIBILITY; GENOTYPE; NERVE EXCITABILITY; NEWBORN DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0034283908     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01629-5     Document Type: Review

References (56)

1. Leppert, M. et al. (1989) Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337, 647-648
2. Lewis, T.B. et al. (1993) Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am. J. Hum. Genet. 53, 670-675
3. Biervert, C. et al. (1998) A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406
4. Singh, N.A. et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18, 25-29
5. Charlier, C. et al. (1998) A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18, 53-55
6. + channels causes epilepsy. Nature 396, 687-690
7. Yang, W-P. et al. (1998) Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J. Biol. Chem. 31, 19419-19423
8. Tinel, N. et al. (1998) The KCNQ2 potassium channel: splice variants, functional and developmental expression, brain localization and comparison with KCNQ3. FEBS Lett. 438, 171-176
9. Cooper, E.C. et al. (2000) Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc. Natl. Acad. Sci. U. S. A. 97, 4914-4919
10. + current in a vertebrate neurone. Nature 283, 673-676
11. Marrion, N.V. (1997) Control of M-current. Annu. Rev. Physiol. 59, 483-504
12. Turski, L. et al. (1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3, 154-171
13. McDonough, J.H. et al. (1997) Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21, 559-579
14. Hamilton, S.E. et al. (1997) Disruption of the ml receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc. Natl. Acad. Sci. U. S. A. 94, 13311-13316
15. Rogawski, M.A. and Porter, R.J. (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with a consideration of developmental stage compounds. Pharmacol. Rev. 42, 223-286
16. Wang, H-S. et al. (1998) KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282, 1890-1893
17. + channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. J. Neurosci. 19, 7742-7756
18. + channels that underlie the neuronal M current. J. Neurosci. 20, 1710-1721
19. Leppert, M.F. and Singh, N. (1999) Susceptibility genes in human epilepsy. Semin. Neurol. 19, 397-405
20. Viskin, S. (1999) Long QT syndromes and torsade de pointes. Lancet 354, 1625-1633
21. Lehmann-Horn, F. and Jurkat-Rott, K. (1999) Voltage-gated ion channels and hereditary disease. Physiol. Rev. 79, 1317-1372
22. Kubisch, C. et al. (1999) KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 437-446
23. + channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 4333-4338
24. Lerche, C. et al. (2000) Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J. Biol. Chem. (in press)
25. Schroeder, B.C. et al. (2000) KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J. Biol. Chem. (in press)
26. 1 muscarinic acetylcholine receptors. J. Physiol. 522, 349-355
27. Browne, D.L. et al. (1995) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene KCNA1. Nat. Genet. 4, 1671-1672
28. Zuberi, S.M. et al. (1999) A novel mutation in the human voltagegated potassium channel gene (Kvl. 1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122, 817-825
29. Zerr, P. et al. (1998) Episodic ataxia mutations in Kvl.1 alter potassium channel function by dominant negative effects or haploinsufficiency. J. Neurosci. 18, 2842-2848
30. Smart, S.L. et al. (1998) Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20, 809-819
31. Rho, J.M. et al. (1999) Developmental seizure susceptibility of Kvl.1 potassium channel knockout mice. Dev. Neurosci. 21, 320-327
32. + channel GIRK2. Proc. Natl. Acad. Sci. U. S. A. 94, 923-927
33. Ptacek, L.J. (1999) Ion channel diseases: episodic disorders of the nervous system. Semin. Neurol. 19, 363-369
34. Schulze-Bahr, E. et al. (1999) The LQT syndromes - current status of molecular mechanisms. Z. Kardiol. 88, 245-254
35. Roden, D.M. (1998) Taking the 'idio' out of 'idiosyncratic': predicting torsades de pointes. Pacing Clin. Electrophysiol. 21, 1029-1034
36. Jongbloed, R.J.E, et al. (1999) Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum. Mutat. 12, 301-310
37. Berthet, M. et al. (1999) C-terminal HERG mutations. The role of hypkalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation 99, 1464-1470
38. Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97, 175-187
39. Steinlein, O.K. et al. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11, 201-203
40. Foreman, S.A. et al. (1996) Alternative mechanisms for pathogenesis of an inherited epilepsy by a nicotinic AChR mutant. Nat. Genet. 396-397
41. Singh, R. et al. (1999) Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann. Neurol. 45, 75-81
42. Escayg, A. et al. (2000) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS + 2. Nat. Genet. 24, 343-345
43. Kwiecinski, H. et al. (1992) Treatment of myotonia with antiarrhythmic drugs. Acta Neurol. Scand. 86, 371-375
44. Weckbecker, K. et al. (2000) Different effects of mexiletine on two mutant sodium channels causing paramyotonia congenita and hyperkalemic periodic paralysis. Neuromuscul. Disord. 10, 31-39
45. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 92, 3381-3386
46. Wang, D.W. et al. (1997) Pharmacological targeting of long QT mutant sodium channels. J. Clin. Invest. 99, 1714-1720
47. + channel opener in the LQT1 form of congenital long-QT syndrome. Circulation 7, 1581-1588
48. Compton, S.J. et al. (1996) Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 94, 1018-1022
49. ++ model in the hippocampal slice preparation. Epilepsy Res. 38, 53-66
50. Kapetanovic, I.M. and Rundfeldt, C. (1996) D-23129: a new anticonvulsant compound. CNS Drug Rev. 2, 308-321
51. Armand, V. et al. (1998) Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices. Epilepsia 41, 28-33
52. + channels in neuronal cells. Eur. J. Pharmacol. 336, 243-249
53. + channel opening effect of the anticonvulsant retigabine in PC12 cells. Epilepsy Res. 35, 99-107
54. Rundfeldt, C. and Netzer, R. (2000) The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neurosci. Lett. 282, 73-76
55. Main, M.J. et al. (2000) Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol. Pharmacol. 58, 253-262
56. Wickenden, A.D. et al. (2000) Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol. (in press)